Efficacy Study of TKcell in Advanced Colorectal Cancer

A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer.

NCT01929421 ·Status: COMPLETED ·Phase: PHASE2

The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer

NCT05628038 ·Status: RECRUITING ·Phase: PHASE2

Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy in Combination With Bevacizumab-FOLFOX

NCT01395667 ·Status: COMPLETED ·Phase: PHASE1

Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer

NCT01952951 ·Status: UNKNOWN ·Phase: PHASE2

PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer

NCT07031011 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer

NCT07309289 ·Status: RECRUITING ·Phase: PHASE3

mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRC

NCT04895137 ·Status: COMPLETED ·Phase: PHASE2

High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer

NCT03008499 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Preoperative Sequential Short-course Radiation Therapy and FOLFOX for Locally Advanced Rectal Cancer

NCT05673772 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

NCT00960427 ·Status: WITHDRAWN ·Phase: PHASE1

Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment

NCT06751914 ·Status: RECRUITING ·Phase: NA

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

NCT04543695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

SCRT + mFOLFOX6 + PD-1 Antibody + Targeted Therapy for HIgh-Risk pMMR/MSS Rectal Cancer

NCT06908031 ·Status: RECRUITING ·Phase: PHASE2

Clinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer

NCT07333053 ·Status: RECRUITING ·Phase: NA

An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)

NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal Cancer

NCT00868569 ·Status: UNKNOWN ·Phase: PHASE4

Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

NCT06751966 ·Status: RECRUITING ·Phase: NA

A Translational Study for Locoregional Recurrence of T4 Colon Cancer

NCT06958926 ·Status: RECRUITING

Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer

NCT06584318 ·Status: RECRUITING ·Phase: NA

Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer

NCT01211210 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer

NCT05799443 ·Status: UNKNOWN ·Phase: PHASE2

Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer

NCT04215731 ·Status: RECRUITING ·Phase: PHASE3

The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer

NCT02487992 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer

NCT07035002 ·Status: RECRUITING ·Phase: PHASE1

Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis

NCT01923987 ·Status: UNKNOWN ·Phase: PHASE2